Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-4251116

  • Global Glucosamine Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: November 2016 | Report Code: HPH-4251116

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

The global glucosamine market is expected to grow at CAGR 14% during period 2016-2022. The glucosamine market is estimated to reach $1.2billion by 2022. Rising geriatric population is the prime factor driving global glucosamine market for the forecasted period. National Institute of Health’s report; An Aging World: 2015, estimated the world’s geriatric population (aged 65 and over) to be 8.5% in 2015. The report predicts geriatric population to reach around 17% by 2050.  Men and Women above 65 years tend to suffer from arthritis and other joint pain diseases. By the year 2040, more than 78 million people aged 18 years and above will suffer from one or other form of Osteoarthritis (OA). Expenditures towards OA treatment for US government alone costs approx. $62.1billion every year. Majority doctors prescribe glucosamine to regulate OA disease. Emerging economies like India and China are increasing investments for preventive healthcare for the forecasted period. The glucosamine market is segmented in terms of applications. Dairy product is among the known common application of glucosamine. Glucosamine in dairy products market are estimated to reach $57million by 2020, at CAGR 15%. By 2025, Countries like India, Pakistan, US, and China will be leading producers of milk and dairy products growing at 3 % annually.

The research report is segmented in terms of applications. Under application, the research report is segmented as nutritional supplements, food & beverage and dairy products. Food & beverage is one of the fastest growing application segments. Europe and Asia Pacific are regions leading in food & beverage market growth. The global demand in food & beverage grew at CAGR 15% to over ~11,700tons in 2020. Japan is the fastest growing consumer market for glucosamine in food and beverage. Japan has over 26% of its total population aged 65 years and above. Geriatric population in Japan is estimated to grow at 4% per annum. Glucosamine market in Japan is growing at CAGR 17% till 2020. Nutritional supplement was leading application segment of glucosamine in the world with market share of 35% in 2015. The nutritional supplement market is growing fastest in US. US accounted for the largest market share (of 71%) in North America for glucosamine. Growing geriatric population and health conscious working people are the contributing factors towards nutritional supplement market growth. Nutritional supplement market share of North America was 27% in 2015. Asia Pacific is the fastest growing market for nutritional supplement in the world, with CAGR of 12.5% till 2022. Growing geriatric population in China, Japan, and Australia are the main drivers of nutritional supplement market in Asia Pacific.

Growing geriatric population, adoption of glucosamine in emerging economies, increasing adoption of food & beverages, increasing prevalence of arthritis and other joint pain diseases and rising vegan diet population are the drivers discussed in the market research report. By the year 2040, more than 78 million people aged 18 years and above will suffer from one or other form of Osteoarthritis (OA). Proper disposal and recycling technique, low awareness of glucosamine material in emerging economies, and traceability & control of supply chain are the challenges deliberated in the research report.

The research report analysed biotechnology reagents market geographically. Region wise the report is segmented as North America, Europe, Asia Pacific, and Rest of the World. North America dominates glucosamine market with market share of 32% in 2015. North America is followed closely by Europe with market share of 29% in 2015. Awareness about glucosamine and nutritional supplements, increasing geriatric population and growing food & beverage industry adopting glucosamine in their products are the factors driving the market in North America and Europe for the forecasted period. Asia Pacific is the fastest growing glucosamine market for the forecasted period. Asia Pacific is anticipated to have market share of 34% by 2022. In 2015, Asia Pacific had over 38% of the world’s total geriatric population. Every five years geriatric population in Asia Pacific is growing at 22%. Increasing geriatric population, increasing health conscious working people, rising adoption of food & beverage, and growing vegan population are the factors driving glucosamine market in Asia Pacific for the forecasted period. Geriatric population in India is estimated to increase up to 3.75% by 2021. Countries like Japan, India, China, Indonesia and Vietnam are among the growing markets for glucosamine in Asia Pacific. Nutritional supplements demand is growing in India, with growing awareness among working youth population. Food Safety and Standards Act 2006 and Food & Drug Administration’s Orphan Drug Act Amendments 1988 are the reference points for regulations for food products including nutritional supplements to be sold in the country.

Some of the leading companies are Alfa Chem, Cargill Inc., Fabrichem Inc., Golden Shell Biochemical Co Ltd., Koyo Chemical Company Ltd., and Marin Biochemical Co Ltd. The report provides comprehensive information like company profile, sales, revenue, market share and contact information. Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in glucosamine market, to increase their global presence. Frutarom Inc., brought 100% shares of nutritional supplement manufacturer, Grow Company Inc., US, for $20million on 18th January 2016. On 29th September 2016, TSI Group Co Ltd., launched GlucosaGreenDF worlds first non-shellfish glucosamine product. TSI Group Co Ltd has their presence in Europe and North America.

 

1.    INTRODUCTION
1.1.    EXECUTIVE SUMMARY
1.2.    MARKET SCOPE
 
2.    MARKET OVERVIEW
2.1.    GLOBAL GLUCOSAMINE MARKET: EVOLUTION & TRANSITION
2.2.    INDUSTRY STRUCTURE
2.3.    MANUFACTURING PROCESS
2.4.    REGULATORY FRAMEWORK
2.5.    TOTAL MARKET ANALYSIS
2.5.1.    TOP 5 FINDINGS
2.5.2.    TOP 5 OPPORTUNITY MARKETS
2.5.3.    TOP 5 COMPANIES
2.5.4.    TOP 3 COMPETITIVE STRATEGIES
2.6.    ESTIMATION ANALYSIS
2.7.    STRATEGIC ANALYSIS
2.7.1.    INVESTMENT VS. ADOPTION MODEL
2.7.2.    360 DEGREE INDUSTRY ANALYSIS
2.7.3.    PORTERS 5 FORCE MODEL
2.7.4.    SEE-SAW ANALYSIS
2.7.5.    PRICING ANALYSIS
2.7.6.    CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.7.    ROI ANALYSIS
2.7.8.    GAP ANALYSIS
2.8.    COMPETITIVE ANALYSIS
2.8.1.    KEY STRATEGIES AND ANALYSIS
2.8.2.    MARKET SHARE
2.8.3.    TOP COMPANY ANALYSIS
2.9.    STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1.    INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2.    OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3.    INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3.    MARKET DETERMINANTS
3.1.    MARKET DRIVERS & MARKET IMPACT
3.1.1.    GROWING GERIATRIC POPULATION
3.1.2.    ADOPTION OF GLUCOSAMINE IN EMERGING ECONOMIES
3.1.3.    INCREASING ADOPTION OF FOOD & BEVERAGES
3.1.4.    INCREASING PREVALENCE OF ARTHRITIS AND OTHER JOINT PAIN DISEASES
3.1.5.    RISING VEGAN DIET POPULATION
3.2.    MARKET RESTRAINTS & MARKET IMPACT
3.2.1.    HIGH COST OF GLUCOSAMINE PRODUCTS
3.2.2.    LESS CONSUMPTION IN EMERGING ECONOMIES
3.2.3.    STRINGENT REGULATORY RULES TOWARDS FMCG’S
3.3.    MARKET OPPORTUNITIES
3.3.1.    GROWING DEMAND IN EMERGING ECONOMIES
3.3.2.    AGING POPULATION
3.4.    MARKET CHALLENGES
3.4.1.    PROPER DISPOSAL AND RECYCLING TECHNIQUE
3.4.2.    LOW AWARENESS OF GLUCOSAMINE MATERIAL IN EMERGING ECONOMIES
3.4.3.    TRACEABILITY & CONTROL OF SUPPLY CHAIN
 
4.    MARKET SEGMENTATION
4.1.    GLOBAL GLUCOSAMINE MARKET BY APPLICATION 2014-2023 ($ MILLION)
4.1.1.    MARKET DEFINITION AND SCOPE
4.1.2.    DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3.    COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4.     OPPORTUNITY MATRIX
4.1.5.     MARKET SEGMENTATION
4.1.5.1.    NUTRITIONAL SUPPLEMENT 2014-2023 ($ MILLION)
4.1.5.1.1.    APPLICATIONS
4.1.5.1.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5.    KEY CONCLUSIONS
4.1.5.2.    FOOD & BEVERAGES 2014-2023 ($ MILLION)
4.1.5.2.1.    APPLICATIONS
4.1.5.2.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5.    KEY CONCLUSIONS
4.1.5.3.    DAIRY PRODUCT 2014-2023 ($ MILLION)
4.1.5.3.1.    APPLICATIONS
4.1.5.3.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5.    KEY CONCLUSIONS
 
5.    COMPETITIVE LANDSCAPE
5.1.    KEY STRATEGIES
5.1.1.    LIST OF M&A
5.1.2.    LIST OF JV
5.1.3.    LIST OF PRODUCT LAUNCHES
5.1.4.    LIST OF PARTNERSHIP
5.2.    TOP 10 COMPANY ANALYSIS – DASHBOARD
 
6.    GLOBAL GLUCOSAMINE MARKET BY REGION (REVENUE ANALYSIS) 2014-2023 ($ MILLION)
6.1.    DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2.    COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3.    OPPORTUNITY MATRIX
6.4.     GEOGRAPHIC SEGMENTATION
6.4.1.    NORTH AMERICA
6.4.1.1.    INDUSTRY APPLICATION ANALYSIS
6.4.1.2.    TOP COUNTRY ANALYSIS
6.4.1.2.1.    U.S.
6.4.1.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.1.2.1.3.    PRICE ANALYSIS
6.4.1.2.1.4.    TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.5.    KEY CONCLUSIONS
6.4.1.2.2.    CANADA
6.4.1.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.1.2.2.3.    PRICE ANALYSIS
6.4.1.2.2.4.    TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.5.    KEY CONCLUSIONS
6.4.2.    EUROPE
6.4.2.1.    INDUSTRY APPLICATION ANALYSIS
6.4.2.2.    TOP COUNTRY ANALYSIS
6.4.2.2.1.    UK
6.4.2.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.1.3.    PRICE ANALYSIS
6.4.2.2.1.4.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.5.    KEY CONCLUSIONS
6.4.2.2.2.    FRANCE
6.4.2.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.2.3.    PRICE ANALYSIS
6.4.2.2.2.4.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.5.    KEY CONCLUSIONS
6.4.2.2.3.    GERMANY
6.4.2.2.3.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.3.3.    PRICE ANALYSIS
6.4.2.2.3.4.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.5.    KEY CONCLUSIONS
6.4.2.2.4.    SPAIN
6.4.2.2.4.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.4.3.    PRICE ANALYSIS
6.4.2.2.4.4.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.5.    KEY CONCLUSIONS
6.4.2.2.5.    ITALY
6.4.2.2.5.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.5.3.    PRICE ANALYSIS
6.4.2.2.5.4.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.5.    KEY CONCLUSIONS
6.4.2.2.6.    REST OF EUROPE
6.4.2.2.6.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.6.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.6.3.    PRICE ANALYSIS
6.4.2.2.6.4.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.5.    KEY CONCLUSIONS
6.4.3.    ASIA PACIFIC
6.4.3.1.    INDUSTRY APPLICATION ANALYSIS
6.4.3.2.    TOP COUNTRY ANALYSIS
6.4.3.2.1.    CHINA
6.4.3.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.1.3.    PRICE ANALYSIS
6.4.3.2.1.4.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.5.    KEY CONCLUSIONS
6.4.3.2.2.    INDIA
6.4.3.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.2.3.    PRICE ANALYSIS
6.4.3.2.2.4.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.5.    KEY CONCLUSIONS
6.4.3.2.3.    JAPAN
6.4.3.2.3.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.3.3.    PRICE ANALYSIS
6.4.3.2.3.4.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.5.    KEY CONCLUSIONS
6.4.3.2.4.    SOUTH KOREA
6.4.3.2.4.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.4.3.    PRICE ANALYSIS
6.4.3.2.4.4.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.5.    KEY CONCLUSIONS
6.4.3.2.5.    AUSTRALIA
6.4.3.2.5.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.5.3.    PRICE ANALYSIS
6.4.3.2.5.4.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.5.    KEY CONCLUSIONS
6.4.3.2.6.    REST OF ASIA PACIFIC
6.4.3.2.6.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.6.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.6.3.    PRICE ANALYSIS
6.4.3.2.6.4.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.5.    KEY CONCLUSIONS
6.4.4.    ROW
6.4.4.1.    INDUSTRY APPLICATION ANALYSIS
6.4.4.2.    TOP COUNTRY ANALYSIS
6.4.4.2.1.    LATIN AMERICA
6.4.4.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.4.2.1.3.    PRICE ANALYSIS
6.4.4.2.1.4.    TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.5.    KEY CONCLUSIONS
6.4.4.2.2.    MIDDLE EAST & AFRICA
6.4.4.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.4.2.2.3.    PRICE ANALYSIS
6.4.4.2.2.4.    TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.5.    KEY CONCLUSIONS
 
7.    COMPANY PROFILES
7.1.    ALFA CHEM
7.1.1.    OVERVIEW
7.1.2.    PRODUCT PORTFOLIO
7.1.3.    KEY INNOVATION SECTOR
7.1.4.    STRATEGIC INITIATIVES
7.1.5.    SCOT ANALYSIS
7.2.    CARGILL INC
7.2.1.    OVERVIEW
7.2.2.    PRODUCT PORTFOLIO
7.2.3.    KEY INNOVATION SECTOR
7.2.4.    STRATEGIC INITIATIVES
7.2.5.    SCOT ANALYSIS
7.3.    FABRICHEM INC
7.3.1.    OVERVIEW
7.3.2.    PRODUCT PORTFOLIO
7.3.3.    KEY INNOVATION SECTOR
7.3.4.    STRATEGIC INITIATIVES
7.3.5.    SCOT ANALYSIS
7.4.    GOLDEN SHELL BIOCHEMICAL CO LTD
7.4.1.    OVERVIEW
7.4.2.    PRODUCT PORTFOLIO
7.4.3.    KEY INNOVATION SECTOR
7.4.4.    STRATEGIC INITIATIVES
7.4.5.    SCOT ANALYSIS
7.5.    KOYO CHEMICAL COMPANY LTD
7.5.1.    OVERVIEW
7.5.2.    PRODUCT PORTFOLIO
7.5.3.    KEY INNOVATION SECTOR
7.5.4.    STRATEGIC INITIATIVES
7.5.5.    SCOT ANALYSIS
7.6.    MARINE BIOCHEMICAL CO LTD
7.6.1.    OVERVIEW
7.6.2.    PRODUCT PORTFOLIO
7.6.3.    KEY INNOVATION SECTOR
7.6.4.    STRATEGIC INITIATIVES
7.6.5.    SCOT ANALYSIS
7.7.    NAVAMEDIC ASA
7.7.1.    OVERVIEW
7.7.2.    PRODUCT PORTFOLIO
7.7.3.    KEY INNOVATION SECTOR
7.7.4.    STRATEGIC INITIATIVES
7.7.5.    SCOT ANALYSIS
7.8.    NUTRACEUTIX INC
7.8.1.    OVERVIEW
7.8.2.    PRODUCT PORTFOLIO
7.8.3.    KEY INNOVATION SECTOR
7.8.4.    STRATEGIC INITIATIVES
7.8.5.    SCOT ANALYSIS
7.9.    NUTRILITE
7.9.1.    OVERVIEW
7.9.2.    PRODUCT PORTFOLIO
7.9.3.    KEY INNOVATION SECTOR
7.9.4.    STRATEGIC INITIATIVES
7.9.5.    SCOT ANALYSIS
7.10.    SCHIFF NUTRITION INTERNATIONAL INC
7.10.1.    OVERVIEW
7.10.2.    PRODUCT PORTFOLIO
7.10.3.    KEY INNOVATION SECTOR
7.10.4.    STRATEGIC INITIATIVES
7.10.5.    SCOT ANALYSIS
7.11.    SIMPY SUPPLEMENTS
7.11.1.    OVERVIEW
7.11.2.    PRODUCT PORTFOLIO
7.11.3.    KEY INNOVATION SECTOR
7.11.4.    STRATEGIC INITIATIVES
7.11.5.    SCOT ANALYSIS
7.12.    TRIARCO INDUSTRIES INC
7.12.1.    OVERVIEW
7.12.2.    PRODUCT PORTFOLIO
7.12.3.    KEY INNOVATION SECTOR
7.12.4.    STRATEGIC INITIATIVES
7.12.5.    SCOT ANALYSIS
7.13.    ALCAN CHEMICAL DIVISION
7.13.1.    OVERVIEW
7.13.2.    PRODUCT PORTFOLIO
7.13.3.    KEY INNOVATION SECTOR
7.13.4.    STRATEGIC INITIATIVES
7.13.5.    SCOT ANALYSIS
7.14.    SYNASIA INC.,
7.14.1.    OVERVIEW
7.14.2.    PRODUCT PORTFOLIO
7.14.3.    KEY INNOVATION SECTOR
7.14.4.    STRATEGIC INITIATIVES
7.14.5.    SCOT ANALYSIS
7.15.    TRIARCO INDUSTRIES INC.,
7.15.1.    OVERVIEW
7.15.2.    PRODUCT PORTFOLIO
7.15.3.    KEY INNOVATION SECTOR
7.15.4.    STRATEGIC INITIATIVES
7.15.5.    SCOT ANALYSIS
 
LIST OF TABLES
1.    GLOBAL GLUCOSAMINE MARKET BY APPLICATION 2014-2023 ($ MILLION)
2.    GLOBAL NUTRITIONAL SUPPLEMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
3.    GLOBAL FOOD & BEVERAGE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4.    GLOBAL DAIRY PRODUCTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5.    NORTH AMERICA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
6.    EUROPE GLUCOSAMINE MARKET2014-2023 ($ MILLION)
7.    ASIA PACIFIC GLUCOSAMINE MARKET2014-2023 ($ MILLION)
8.    REST OF THE WORLD GLUCOSAMINE MARKET2014-2023 ($ MILLION)
 
LIST OF FIGURES
1.    GLOBAL GLUCOSAMINE MARKET BY NUTRITIONAL SUPPLEMENTS 2014-2023 ($ MILLION)
2.    GLOBAL GLUCOSAMINE MARKET BY FOOD & BEVERAGES 2014-2023 ($ MILLION)
3.    GLOBAL GLUCOSAMINE MARKET BY DAIRY PRODUCTS 2014-2023 ($ MILLION)
4.    UNITED STATES (U.S.) GLUCOSAMINE MARKET2014-2023 ($ MILLION)
5.    CANADA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
6.    UNITED KINGDOM (UK) GLUCOSAMINE MARKET2014-2023 ($ MILLION)
7.    FRANCE GLUCOSAMINE MARKET2014-2023 ($ MILLION)
8.    GERMANY GLUCOSAMINE MARKET2014-2023 ($ MILLION)
9.    SPAIN GLUCOSAMINE MARKET2014-2023 ($ MILLION)
10.    ITALY GLUCOSAMINE MARKET2014-2023 ($ MILLION)
11.    ROE GLUCOSAMINE MARKET2014-2023 ($ MILLION)
12.    INDIA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
13.    CHINA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
14.    JAPAN GLUCOSAMINE MARKET2014-2023 ($ MILLION)
15.    KOREA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
16.    AUSTRALIA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
17.    ROAPAC GLUCOSAMINE MARKET2014-2023 ($ MILLION)
18.    LATIN AMERICA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
19.    MENA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
20.    AFRICA GLUCOSAMINE MARKET2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

UPCOMING REPORTS

No upcoming reports available under this subcategory.

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion